EAST RUTHERFORD, N.J., Oct. 26, 2012 /PRNewswire/ -- Cambrex Corporation (NYSE: CBM) announced that third quarter 2012 financial results will be released on Wednesday, October 31, 2012 after the market closes.
The Company will host a conference call to discuss the financial results.
Third Quarter 2012 Earnings Conference Call
When:
Thursday, November 1, 2012 at 8:30 a.m. Eastern Time
Cambrex Corporation is an innovative life sciences company that provides products, services and technologies to accelerate the development and commercialization of small molecule therapeutics. We offer Active Pharmaceutical Ingredients (APIs), advanced intermediates and enhanced drug delivery products for branded and generic pharmaceuticals. Our development and manufacturing capabilities include enzymatic biotransformations, high potency APIs, high energy chemical synthesis, controlled substances and formulation of finished dosage form products. For more information, please visit www.cambrex.com.